BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ponziani FR, Zocco MA, Garcovich M, D’Aversa F, Roccarina D, Gasbarrini A. What we should know about portal vein thrombosis in cirrhotic patients: A changing perspective. World J Gastroenterol 2012; 18(36): 5014-5020 [PMID: 23049208 DOI: 10.3748/wjg.v18.i36.5014] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Saracoglu A, Saracoglu KT. Coagulopathy during liver transplantation. J Anaesthesiol Clin Pharmacol 2018;34:289-95. [PMID: 30386008 DOI: 10.4103/joacp.JOACP_390_16] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Cagin YF, Atayan Y, Erdogan MA, Dagtekin F, Colak C. Incidence and clinical presentation of portal vein thrombosis in cirrhotic patients. Hepatobiliary Pancreat Dis Int 2016;15:499-503. [PMID: 27733319 DOI: 10.1016/s1499-3872(16)60092-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
3 Ma J, Yan Z, Luo J, Liu Q, Wang J, Qiu S. Rational classification of portal vein thrombosis and its clinical significance. PLoS One. 2014;9:e112501. [PMID: 25393320 DOI: 10.1371/journal.pone.0112501] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
4 Cheng J, Zhu XQ. Progress in research of venous thromboembolism in hospitalized patients with digestive system diseases. Shijie Huaren Xiaohua Zazhi 2018; 26(18): 1089-1094 [DOI: 10.11569/wcjd.v26.i18.1089] [Reference Citation Analysis]
5 Qi XS, Bai M, Fan DM. Nonselective β-blockers may induce development of portal vein thrombosis in cirrhosis. World J Gastroenterol 2014;20:11463-6. [PMID: 25170238 DOI: 10.3748/wjg.v20.i32.11463] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
6 Pieri G, Theocharidou E, Burroughs AK. Liver in haematological disorders. Best Practice & Research Clinical Gastroenterology 2013;27:513-30. [DOI: 10.1016/j.bpg.2013.06.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
7 Rabie H, Othman W, Elsabaawy DM, Elshemy EE, Abdelmageed N, Khalaf FA, Bedair HM. Janus Kinase-2 Mutation Associated Portal Vein Thrombosis Complicating Liver Cirrhosis and Hepatocellular Carcinoma. Asian Pac J Cancer Prev 2021;22:267-75. [PMID: 33507708 DOI: 10.31557/APJCP.2021.22.1.267] [Reference Citation Analysis]
8 Faccia M, Ainora ME, Ponziani FR, Riccardi L, Garcovich M, Gasbarrini A, Pompili M, Zocco MA. Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate. World J Gastroenterol 2019; 25(31): 4437-4451 [PMID: 31496623 DOI: 10.3748/wjg.v25.i31.4437] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
9 Trebicka J, Strassburg CP. Etiology and Complications of Portal Vein Thrombosis. Viszeralmedizin. 2014;30:375-380. [PMID: 26288604 DOI: 10.1159/000369987] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
10 Benjilali L, Essaadouni L. [Splanchnic venous thrombosis: A monocentric study of 31 cases]. J Mal Vasc 2016;41:26-35. [PMID: 26725444 DOI: 10.1016/j.jmv.2015.12.001] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Zhou J, Yang JH. Risk factors for nontumoral portal vein thrombosis in patients with liver cirrhosis. Shijie Huaren Xiaohua Zazhi 2015; 23(18): 2886-2893 [DOI: 10.11569/wcjd.v23.i18.2886] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Chatelin S, Pop R, Giraudeau C, Ambarki K, Jin N, Séverac F, Breton E, Vappou J. Influence of portal vein occlusion on portal flow and liver elasticity in an animal model. NMR Biomed 2021;34:e4498. [PMID: 33634498 DOI: 10.1002/nbm.4498] [Reference Citation Analysis]
13 Ghabril M, Agarwal S, Lacerda M, Chalasani N, Kwo P, Tector AJ. Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients. Transplantation. 2016;100:126-133. [PMID: 26050013 DOI: 10.1097/tp.0000000000000785] [Cited by in Crossref: 67] [Cited by in F6Publishing: 19] [Article Influence: 11.2] [Reference Citation Analysis]
14 Shukla A, Giri S. Portal Vein Thrombosis in Cirrhosis. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ponziani FR, Zocco MA, Cerrito L, Gasbarrini A, Pompili M. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications. Expert Rev Gastroenterol Hepatol. 2018;12:641-656. [PMID: 29806487 DOI: 10.1080/17474124.2018.1481747] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 10.5] [Reference Citation Analysis]
16 Li MX, Zhang XF, Liu ZW, Lv Y. Risk factors and clinical characteristics of portal vein thrombosis after splenectomy in patients with liver cirrhosis. Hepatobiliary Pancreat Dis Int. 2013;12:512-519. [PMID: 24103282 DOI: 10.1016/s1499-3872(13)60081-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
17 Ikura Y, Osuga T. Changing common sense: Anti-platelet/coagulation therapy against cirrhosis. World J Hepatol 2015; 7(13): 1730-1734 [PMID: 26167245 DOI: 10.4254/wjh.v7.i13.1730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Li CJ, Yang ZH, Shi XL, Lu FG, Liu DL. Risk factors for portal vein thrombosis in cirrhotic patients: A meta-analysis. Shijie Huaren Xiaohua Zazhi 2017; 25(3): 241-251 [DOI: 10.11569/wcjd.v25.i3.241] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Nacif LS, Zanini LY, Pinheiro RS, Waisberg DR, Rocha-Santos V, Andraus W, Carrilho FJ, Carneiro-D'Albuquerque L. Portal vein surgical treatment on non-tumoral portal vein thrombosis in liver transplantation: Systematic Review and Meta-Analysis. Clinics (Sao Paulo) 2021;76:e2184. [PMID: 33503185 DOI: 10.6061/clinics/2021/e2184] [Reference Citation Analysis]
20 Takahashi S, Kimura T, Kenjo M, Nishibuchi I, Takahashi I, Takeuchi Y, Doi Y, Kaneyasu Y, Murakami Y, Honda Y, Aikata H, Chayama K, Nagata Y. Case reports of portal vein thrombosis and bile duct stenosis after stereotactic body radiation therapy for hepatocellular carcinoma: Portal vein/bile duct toxicity after SBRT. Hepatol Res 2014;44:E273-8. [DOI: 10.1111/hepr.12241] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
21 Cagin YF, Bilgic Y, Berber İ, Yildirim O, Erdogan MA, Firat F, Arslan AK, Colak C, Seckin Y, Harputluoglu M. The risk factors of portal vein thrombosis in patients with liver cirrhosis. Exp Ther Med 2019;17:3189-94. [PMID: 30936992 DOI: 10.3892/etm.2019.7300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
22 Gao Y, Liu H, Tang F, Zhang X, Li F, Ye Q, Yuan H, Lv H, Han T. Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: A meta-analysis. Clin Res Hepatol Gastroenterol 2021;45:101649. [PMID: 33601064 DOI: 10.1016/j.clinre.2021.101649] [Reference Citation Analysis]
23 Ogino R, Hosono M, Ishii K, Tatsumi D, Tsutsumi S, Miki Y, Masuoka Y, Shimatani Y, Miki Y. A dose-volume intercomparison of volumetric-modulated arc therapy, 3D static conformal, and rotational conformal techniques for portal vein tumor thrombus in hepatocellular carcinoma. J Radiat Res 2013;54:697-705. [PMID: 23418389 DOI: 10.1093/jrr/rrs139] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Chaireti R, Rajani R, Bergquist A, Melin T, Friis-Liby IL, Kapraali M, Kechagias S, Lindahl TL, Almer S. Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event. Thromb Res. 2014;134:455-461. [PMID: 24913997 DOI: 10.1016/j.thromres.2014.05.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
25 Pettinari I, Vukotic R, Stefanescu H, Pecorelli A, Morelli M, Grigoras C, Sparchez Z, Andreone P, Piscaglia F; BO-LIVES (BOlogna LIVEr vascular Studies). Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis. Am J Gastroenterol. 2019;114:258-266. [PMID: 30538290 DOI: 10.1038/s41395-018-0421-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 14.7] [Reference Citation Analysis]
26 Khripun AI, Shurygin SN, Mironkov AB, Pryamikov AD. [Venous acute disturbance of mesenteric circulation: diagnosis and treatment]. Khirurgiia (Mosk) 2017;:95-102. [PMID: 29286040 DOI: 10.17116/hirurgia20171295-102] [Reference Citation Analysis]
27 Aggarwal A, Puri K, Liangpunsakul S. Deep vein thrombosis and pulmonary embolism in cirrhotic patients: Systematic review. World J Gastroenterol 2014; 20(19): 5737-5745 [PMID: 24914335 DOI: 10.3748/wjg.v20.i19.5737] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
28 Dai J, Qi X, Li H, Guo X. Role of D-dimer in the Development of Portal Vein Thrombosis in Liver Cirrhosis: A Meta-analysis. Saudi J Gastroenterol 2015;21:165-74. [PMID: 26021776 DOI: 10.4103/1319-3767.157567] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
29 Zhou J, Yang JH. Progress in treatment of nontumoral portal vein thrombosis in liver cirrhosis. Shijie Huaren Xiaohua Zazhi 2015; 23(5): 735-740 [DOI: 10.11569/wcjd.v23.i5.735] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Kumar A, Sharma P, Arora A. Review article: portal vein obstruction - epidemiology, pathogenesis, natural history, prognosis and treatment. Aliment Pharmacol Ther 2015;41:276-92. [DOI: 10.1111/apt.13019] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
31 Lapumnuaypol K, DiMaria C, Chiasakul T. Safety of direct oral anticoagulants in patients with cirrhosis: a systematic review and meta-analysis. QJM 2019;112:605-10. [PMID: 31135040 DOI: 10.1093/qjmed/hcz127] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
32 Molinari M, Fernandez-Carrillo C, Dai D, Dana J, Clemente-Sanchez A, Dharmayan S, Kaltenmeier C, Liu H, Behari J, Rachakonda V, Ganesh S, Hughes C, Tevar A, Al Harakeh H, Emmanuel B, Humar A, Bataller R. Portal vein thrombosis and renal dysfunction: a national comparative study of liver transplant recipients for NAFLD versus alcoholic cirrhosis. Transpl Int 2021;34:1105-22. [PMID: 33780554 DOI: 10.1111/tri.13873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Yu S, Feng ZJ. Tissue factor pathway inhibitor and liver diseases. Shijie Huaren Xiaohua Zazhi 2013; 21(11): 996-1001 [DOI: 10.11569/wcjd.v21.i11.996] [Reference Citation Analysis]
34 Costache RS, Dragomirică AS, Dumitraș EA, Mariana J, Căruntu A, Popescu A, Costache DO. Portal vein thrombosis: A concise review (Review). Exp Ther Med 2021;22:759. [PMID: 34035856 DOI: 10.3892/etm.2021.10191] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]